Driving drug delivery innovation at Combination Products Seminar 2026 Japan

SHL Medical is set to return to Combination Products Seminar 2026 Japan, taking place September 16-17 in Tokyo. Bringing together experts in combination products and drug delivery, the event provides a forum to discuss next-generation devices in the Asia-Pacific region and beyond. 

At the event, we will share insights into the design and development of advanced drug delivery systems. Markus Bauss, SHL Medical’s Head of Business Development APAC, and Nils Ronquist, MSc, SHL Medical’s Principal Engineer, Customer Delivery and Care, will present SHL Medical’s approach to designing specialized drug delivery systems, including devices for lyophilized formulations such as Reunite, as well as technologies for microliter-scale dose delivery. 

Visitors can also explore our latest device portfolio at our Tabletop #12. Alongside Reunite, we will also showcase Quanta, our automatic, multi-fixed-dose pen injector built for once-weekly cardiometabolic therapies, introduced earlier this year. Our proven modular autoinjector platform Molly and our large-volume cartridge-based autoinjector will also be available for demonstration. 

Register today to join us at Combination Products Seminar 2026 Japan and exchange perspectives on the evolving landscape of drug delivery and combination product development. We look forward to connecting with you in Tokyo.